Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial [Hematologic Malignancy]

Conclusion
HT in patients with FL who previously responded to immunochemotherapy is an early event associated with a poor outcome that may deserve intensive salvage with autologous stem cell transplantation. These data emphasize the necessity for biopsy at the first recurrence of FL.

Source: Journal of Clinical Oncology - July 19, 2016 Category: Cancer & Oncology Authors: Sarkozy, Trneny, Xerri, Wickham, Feugier, Leppa, Brice, Soubeyran, Gomes Da Silva, Mounier, Offner, Dupuis, Caballero, Canioni, Paula, Delarue, Zachee, Seymour, Salles, Tilly Tags: Risk factors, Epidemiology, Diagnosis & Staging, Chemotherapy Hematologic Malignancy Source Type: research